脑脊液-静脉瘘患者脑脊液β-痕量蛋白水平升高
本研究前瞻性纳入71例因疑诊脑脊液-静脉瘘而行侧卧位脊髓造影的患者,检测脑脊液β-痕量蛋白水平。结果显示CVF阳性组平均BTP约为阴性组两倍。结果提示脑脊液BTP可能作为识别CVF的潜在生物标志物。
要点
- CVF阳性者脑脊液BTP水平约为阴性者两倍,可辅助提高诊断信心。
- BTP每升高1单位,确诊CVF相对阴性结果的校正后优势比增加48%。
- BTP可能弥补自发性颅内低压缺乏客观生物标志物的诊断缺口。
核心结论
- CVF患者脑脊液BTP水平约为脊髓造影阴性患者的两倍,提示BTP可作为识别CVF的潜在生物标志物。
研究设计与样本
- 前瞻性队列研究,共纳入71例因疑诊CVF行侧卧位脊髓造影的患者,其中64例行数字减影脊髓造影,7例行光子计数探测器CT脊髓造影。
- 脊髓造影结果由两名独立神经放射科医师判读,分为明确阳性、阴性或不确定;BTP组间比较采用Kruskal-Wallis检验,并拟合多项logistic回归。
关键影像表现/征象
- 71例中22例CVF明确阳性,15例不确定,34例阴性;阳性组平均BTP最高,阴性组最低。
诊断标准与关键数值
- CVF阳性组平均BTP为34.4 mg/L(SD 8.7),不确定组为21.2 mg/L(SD 7.9),阴性组为16.8 mg/L(SD 5.2),组间比较p<0.0001。
- 校正年龄和性别后,BTP每升高1单位,获得明确阳性相对阴性脊髓造影结果的几率增加48%。
临床应用与阅片要点
- 对于临床疑诊自发性颅内低压且脊髓造影结果不确定的患者,脑脊液BTP水平可为诊断提供参考。
- BTP检测不能替代脊髓造影定位瘘口,仍应结合影像学检查综合判断。
局限性
- 原文未报告局限性的具体内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Spontaneous Intracranial Hypotension continues to be an underdiagnosed and debilitating disease. One contributing factor of the diagnostic challenge is the lack of objective biomarkers. Beta trace protein (BTP) is the most abundantly CNS derived protein in the CSF. The purpose of this study was to evaluate CSF BTP levels in patients who underwent lateral decubitus myelography for CSF-venous fistula (CVF) workup and evaluate if BTP levels could differentiate those with positive and negative myelogram.
MATERIALS AND METHODS: 71 patients who underwent lateral decubitus myelography were prospectively enrolled and had CSF measured for BTP. The myelogram results were evaluated by two independent neuroradiologists and classified as definite (2 positive reads), negative (2 negative reads), or indeterminate (any other combination). Continuous variables were described using means, standard deviations, medians, and ranges, and compared across groups using the Kruskal-Wallis test. To evaluate whether BTP levels were associated with myelogram results, a multinomial logistic regression model was fitted with myelogram result (Negative, Indeterminate, Definite) as the outcome.
RESULTS: Of the 71 patients, the mean age was 51.2 years (SD 15.4) and 44 patients were female (62%). 64 patients (90.1%) underwent DSM and 7 underwent photon counting detector-CT myelography. 22 patients (30.1%) were positive (mean BTP 34.4 mg/L, SD 8.7), 15 (21.1%) were indeterminate (mean BTP 21.2 mg/L, SD 7.9), and 34 (47.9%) were negative for CVF (mean BTP 16.8 mg/L (SD 5.2) (p < 0.0001). For each unit increase in BTP, there is 48% increase in odds of having a definite compared to negative myelogram result after adjusting for age and sex.
CONCLUSION: Patients with CVF had twice the CSF BTP level compared to those with a negative myelogram. This suggests that CSF BTP levels could be used as a potential biomarker to identify patients with CVF.
引用
- Mark, Habibi, Kim, et al. Elevated CSF Beta Trace Protein Levels in Patients with CSF-Venous Fistulas. AJNR Am J Neuroradiol. 2026. PMID: 42270352. doi:10.3174/ajnr.A9463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。